Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.
High plasma concentrations of homocysteine, lipoprotein(a) and fibrinogen are accompanied by an increased risk for cardiovascular complications in the general population. All three parameters are markedly elevated in patients with renal disease, a group with a high prevalence and incidence of cardiovascular complications. This review discusses these parameters in such patients in relation to the occurrence of atherosclerotic complications.
Kronenberg
F
F
Institute of Medical Biology and Human Genetics, University of Innsbruck, Austria. florian.kronenberg@uibk.ac.at
D001161:Arteriosclerosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology*; D002908:Chronic Disease; D005340:Fibrinogen / Q000378:metabolism; D005492:Folic Acid / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood; D006801:Humans; D007674:Kidney Diseases / Q000097:blood* / Q000150:complications* / Q000188:drug therapy; D017270:Lipoprotein(a) / Q000097:blood / Q000235:genetics; D012307:Risk Factors
D017270:Lipoprotein(a); D006710:Homocysteine; D005340:Fibrinogen; D005492:Folic Acid